Catalyst Wire Dossier Catalyst Wire Dossier

CelAgace OraRinse Solution

· CelaCare Technologies, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CelAgace OraRinse Solution, covering 2024-02-09 to 2024-02-09. Get the full timeline:

Most recent: Clinical Trial Update: CelAgace™ OraRinse Solution for Treatment of Candidiasis [Phase 1, Phase 2]

See pricing